Novavax stock: buy or sell

NVAX stock price: $127.16 -3.27% At close on Jan 26th, 2021

Updated on:
Jan 27th, 2021


Novavax stock brief

  • Novavax stock dropped -3.27% to close at $127.16 on the stock market on Tuesday.

Should I buy Novavax stock?

All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is $NVAX stock a buy?

In the current situation of Novavax there is not any eligible buy setup. This doesn't mean we expect a selloff for $NVAX in coming sessions, or that it may not rise higher. Simply, it doesn't match our recommended trading systems

Should I sell Novavax stock?

"To sell or not to sell", if you are holding Novavax shares?. Just as when we have to buy shares, deciding when is appropiate time to sell is not a haphazard decision, and we must use our own trading style. When selling, as well as buying, detailed strategies are very easy to use but are only valid for selling stocks in your porfolio, not for shorting Novavax stock

A guiding principle is that you should not hold a trade that generates greater losses than those expected upon purchase. When to sell your stock should always be dictated by the stop-loss (automatic or manual)

Is it time to sell Novavax stock?

Currently, Novavax stock doesn't match any of our preferred sell setups, so if you hold Novavax shares and your operation is in profit probably is not time to sell now

Novavax ratings

In the previous month we couldn't find any rating for Novavax

Novavax stock analysis

SMAs overview

NVAX stock SMAs chart

Supports and resistances

The current resistances are:

  • R1: $130.00 (2.23% above)
  • R2: $132.80 (4.44% above)
  • R3: $137.58 (8.19% above)
  • The current support levels are:

  • S1: $126.54 (-0.49% below)
  • S2: $125.20 (-1.54% below)
  • S3: $125.00 (-1.70% below)
  • Bollinger bands

    NVAX stock Bollinger Bands chart

    Relative strength index

    The RSI dropped below the overbought level of 70 in early December after just crossing to the overbough zone for a single day (weak signal). The RSI reading on Tuesday was 53.66. Since that level was lost, Novavax price sank a 8.85%

    NVAX stock RSI chart

    Novavax stock price history

    Novavax went public priced at an adjusted price1 of $67.50 on Dec 1995. Since then, NVAX stock has risen by 88.39%, with an average of 3.54% per year. An investment of thousand dollars on the IPO would be valued $1,883.85 today.

    1: Adjusted price after possible price splits or reverse-splits

    NVAX stock price history chart

    Price target for Novavax stock

    How much a stock will be priced tomorrow or next week is quite unpredictable. Banks and financial organisations publish their analysis forecasting how a particular stock will performance in the future.

    Along with buy or sell recommendations, financial institutions release their price forecasts based on the stock price action and the company fundamental data. Most of these predictions follow the release of new financial information by the company, and many times. Again, these predictions are not direct recommendations for small investors and must not be followed blindly.

    In the last 30 days we couldn't find any price target posted for Novavax stock.

    Earnings and financials

    Last November, Novavax, Inc. ($NVAX) posted EPS for that far worsened Market expectations. Quarterly EPS was $-3.21 per share from an estimated $1.73. This Q3 report represents an earnings surprise of -285.55%. Estimated turnover was $230.6 million but Novavax severely failed to match by 31.90%, posting $157.0 million.

    Same quarter last year, reported EPS was $-0.74, so recently reported EPS means a loss of -333.78%. Looking at turnover, figures skyrocketed a 6,163.42% compared to $25.1M same quarter a year ago.

    Novavax ($NVAX) is hosting the Q4 earnings call next March.

    Novavax performance

    NVAX performance compared
    Novavax ($NVAX) -0.30% 39.70% -8.80%

    The comments published in this post are personal and should not be followed as recommendations for you to buy or sell shares. The author of this report does not know the individual circumstances of the reader, his or her finances or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Thoughts are posted for educative reasons only

    Novavax summary

    Tuesday, January 26th, 2021
    Day range$126.68 - $132.47
    Previous close$131.46
    Session gain-3.27%
    Average true range$11.00
    50d mov avg$117.39
    100d mov avg$108.62
    200d mov avg$94.28
    Earnings dateMarch 10th, 2021

    Frequently asked questions

    What is Novavax stock symbol?

    Novavax, Inc. is a public company trading in the US stock market with the NVAX symbol

    Is Novavax stock a buy or sell?

    Novavax had no ratings in the last 4 weeks Read the article to get additional tips on trading NVAX stock.

    Will NVAX go up?

    There were no predictions posted by analysts in the last 4 weeks for Novavax.

    Latest Novavax news